Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
Pharmacology, Toxicology and Pharmaceutical Science
3
3%
Psychology
3
3%
Biochemistry, Genetics and Molecular Biology
2
2%
Other
8
7%
Unknown
44
39%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2025.
All research outputs
#3,310,617
of 34,545,128 outputs
Outputs from Journal of Thrombosis & Haemostasis
#815
of 5,383 outputs
Outputs of similar age
#33,766
of 301,694 outputs
Outputs of similar age from Journal of Thrombosis & Haemostasis
#9
of 51 outputs
Altmetric has tracked 34,545,128 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,383 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 301,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.